Exchange: NYSEMkt·Updated 07:48 PM EST

ARMP News

News
all
press releases
Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Beats Revenue Estimates
Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of +57.90% and +252.33%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Beats Revenue Estimates
Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of +57.90% and +252.33%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Liquidia Corporation (LQDA) delivered earnings and revenue surprises of +3.90% and +20.72%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Starling Oncology, Inc. (STLN) delivered earnings and revenue surprises of -85.71% and +0.93%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Krystal Biotech (KRYS) delivered earnings and revenue surprises of +11.41% and +2.16%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
The market is once again rewarding investors willing to look beyond the headline indexes; NeOnc Technologies Holdings (NASDAQ:NTHI), Armata Pharmaceuticals (NYSEAMERICAN:ARMP), Definium Therapeutics (NASDAQ:DFTX), Basel Medical Group (NASDAQ:BMGL), Blue Moon Metals (NASDAQ:BMM) and The Elmet Group (NASDAQ:ELMT).
24-7 Market News
Armata Pharmaceuticals (ARMP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update PR Newswire LOS...
PR Newswire
Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 PR Newswire LOS ANGELES, May 7, 2026 Enables more frequent...
PR Newswire
Armata Pharmaceuticals Announces Structural Biology Publication in 'Communications Biology' Armata Pharmaceuticals Announces Structural Biology Publication in 'Communications Biology' PR Newswire LOS...
PR Newswire
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results PR Newswire LOS ANGELES...
PR Newswire

Advertisement|Remove ads.